Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients

NCT ID: NCT04457999

Last Updated: 2020-07-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-20

Study Completion Date

2020-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lipiflow treatment

Lipiflow thermal pulsation prior to cataract surgery

Group Type EXPERIMENTAL

Lipiflow Thermal pulsation

Intervention Type DEVICE

Single vectored thermal pulsation treatment for dry eye

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lipiflow Thermal pulsation

Single vectored thermal pulsation treatment for dry eye

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 21, who will get catarct surgeyr
* Patients whose visual acuity anticipated better than 20/25 after surgery
* Patients with informed consent
* Patients with meibomian gland dysfunction

Exclusion Criteria

* ocular injury, active injection
* uncontrolled systemic disease
* Contact lens wear within 1 month
* Allergic to fluorescein sodium or topical anesthetics
* ocular surgery or trauma within 6 months
* disorder of lid anatomy
* other reason for decreased vision other than cataract
* anticipated visual acuity less than 20/25
* Patients less than 20 years.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samsung Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

tae-young chung

M.D. Ph.D

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Samsung Medical Center

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tae-Young Chung, MD. PhD

Role: CONTACT

82-2-3410-3563

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tae-Young Chung

Role: primary

+82-10-9933-3563

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-03-011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of a Trifocal Lens
NCT04545671 COMPLETED
Eyelid Closure in Keratometry
NCT07297849 RECRUITING NA